Yong Bai specialises in Antitrust and Competition issues and has more than 10 years of experience advising Chinese and multinational corporations on business investment, regulatory matters and investigations across a range of industries.
Yong's deal experience includes Pfizer's US$160 billion merger with Allergan; inbound investments into China for multinationals like Coca-Cola and private equity firms; and outbound transactions by Chinese investors such as COFCO's acquisitions of Noble Agri and Nidera. Yong has worked in the London and Brussels offices, and prior to joining the firm, he worked for the PRC's Ministry of Commerce. He received his Bachelor of Laws from Shanghai International Studies University and his LLM from Tsinghua Law School and Columbia Law School. He is fluent in English and Mandarin.
- Pfizer on its USD 160 billion merger with Allergan. The transaction was the world's largest ever merger in terms of value to date.
- GE on its USD 32 billion merger of its oil and gas business with Baker Hughes International.
- The Coca-Cola Company on its restructuring of its bottling business in China through a series of inter-related transactions with its partners, Swire Beverages Holdings Limited and COFCO Coca-Cola Beverages limited
- COFCO Corporation on its acquisition of Noble Agri and Nidera – coordinating antitrust and foreign investment filings in 15 jurisdictions in total, including China, the EU and the US
-
Clifford Chance advises GE on global antitrust and merger clearance for its $21.4 billion sale of its BioPharma business
24 March 2020
Client Work -
Clifford Chance advises iron and steel manufacturer China Baowu on US$660 million H share offer
26 November 2019
Client Work -
Clifford Chance advises Bank of China (Hong Kong) on JV to establish virtual bank in Hong Kong
3 April 2019
Client Work -
Clifford Chance advises Tata Steel on US$327 million divestment of SEA business
1 February 2019
Client Work -
Clifford Chance advises China Jianyin Investment Limited, JIC Huawen Investment Limited and Tamar Alliance Capital on acquisition of Nature's Care
16 April 2018
Client Work
Contact details
- Clifford Chance, Beijing
- +861065352286
- Email me
- Save my Vcard
- Speaks Mandarin and English
- Practice area Antitrust, EU & trade
- Sector Consumer goods & retail , Energy & resources , Healthcare, life sciences & chemicals , Industrials , Telecommunications, media & technology
Career and qualifications
- Shanghai International Studies University (LLB) 2003
- Admitted as a lawyer in the People's Republic of China 2006
- Tsinghua University (LLM) 2007
- Admitted as an Attorney-at-Law in New York 2010
- Partner since May 2018
Professional bodies
- New York Bar Association
Awards and citations
- Up and Coming
Chambers Asia-Pacific 2016 - 2018 - Associate to Watch
Chambers Asia-Pacific 2012 - 2015 - Competition – Rising Star
China Law and Practice 2014